Alzheimer’s disease affects millions of people worldwide; it’s often a disease that is undetectable until it’s too late. However, a new set of national guidelines are being released that will help catch signs of the disease earlier. David Shenk, author of “The Forgetting: Alzheimer’s, Portrait of an Epidemic,” explains the latest guidelines. The guidelines concern methods that assess brain changes including brain scans, tests of cerebral spinal fluid and other biomarkers. The ability to find markers means more research into the possibility of developing drugs to combat Alzheimer’s.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!